BOVINE BLOOD PLASMA DERIVATIVES MARKET ANALYSIS
Bovine Blood Plasma Derivatives Market - Restraints
Availability of prominent alternatives to bovine blood plasma derivatives is expected to hamper the market growth. For Instance, in April 2015, Rocky Mountain Biologicals, Inc. – a life science and bioprocessing company — launched high-performance Fetal Bovine Serum alternative — Fetalgro. Fetalgro is proprietary blend of a calf serum base and proprietary additives that matches the Fetal Bovine Serum’s (FBS) cell growth capabilities in CHO, MRC-5, Vero, and a wide range of other cell lines.
Bovine Blood Plasma Derivatives Market- Drivers
Increasing use of bovine blood plasma derivatives in biopharmaceutical companies for cell culture technique, biotechnology, and research and development is expected to drive the market growth. For Instance, in November 2018, Wageningen University initiated the preclinical trial for Bovine plasma protein powder to assess the protein digestion kinetics and protection of the epithelial barriers including other markers for identification of gastrointestinal health, metabolic health, and vascular health, and satiating properties.
Bovine Blood Plasma Derivatives Market Report Snapshots
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize NowWant to Buy a Report but have a Limited Budget?
We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail
Request Discount
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients